DGNOF(DGNOF)
DGNOF
No analyst ratings available
No analyst price targets available for DGNOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $114,695 | $87,317 | $202,115 | $172,532 | $239,306 | $266,834 | $154,016 | $122,867 |
| Low | $114,695 | $87,317 | $202,115 | $172,532 | $239,306 | $266,834 | $154,016 | $122,867 |
| High | $114,695 | $87,317 | $202,115 | $172,532 | $239,306 | $266,834 | $154,016 | $122,867 |
| EBITDA Avg | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| Low | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| High | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| EBIT Avg | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| Low | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| High | $-114,695 | $-87,317 | $-202,115 | $-172,532 | $-239,306 | $-266,834 | $-154,016 | $-122,867 |
| Net Income Avg | $-1M | $-1M | $-1M | $-1M | $-1M | — | — | — |
| Low | $-1M | $-1M | $-1M | $-1M | $-1M | — | — | — |
| High | $-1M | $-1M | $-1M | $-1M | $-1M | — | — | — |
| EPS Avg | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | — | — | — |
| Low | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | — | — | — |
| High | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | — | — | — |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / — | 1 / — | 1 / — |